IRCT20230510058149N1CompletedUnknown
The effectiveness of short-term solution-oriented therapy (SFBT ) on psychological distress and somatization disorder in patients with breast cancer.
Mohaghegh Ardabili University0 sites30 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40 years to 55 years (—)
- Sex
- Female
Inclusion Criteria
- •All women with breast cancer referred to Rasht oncology centers
- •Moderate or greater positive screening for psychological distress and somatization disorder
Exclusion Criteria
- •Abuse of drugs and alcohol
- •Receiving all kinds of drug and psychological treatments in the last six months
Investigators
Similar Trials
Completed
Unknown
The effect of short-term solution-oriented treatment on depression, anxiety and Obsessive Compulsive DisorderIRCT20230726058935N1Semnan University of Medical Sciences120
Completed
Not Applicable
Comparing the efficacy of long-term and short-term doses of letrozole in ovulation induction among patients with polycystic ovary syndromepolycystic ovary syndrome.E28.2IRCT2016030926962N2Vice chancellor for research Urmia University of Medical Sciences200
Recruiting
Phase 3
Examining the Effectiveness of solution-focused brief consolation on mothers with gestational diabetes under insulin treatmentstress,anexity,depression, in mothers with gdm.Gestational diabetes mellitus in pregnancyO24.41IRCT20200202046339N1Arak University of Medical Sciences56
Recruiting
Not Applicable
Investigating the effect of Solution-Focused Brief Therapy on Psychological Well-being and Psychological distress of mothers with Prermature Neonates hospitalized in Neonatal Intensive Care UnitIRCT20200728048234N1Kerman University of Medical Sciences60
Not yet recruiting
Phase 3
Evaluation of the Safety and Efficacy of Short-term A 002 Treatment in Subjects with Acute Coronary SyndromesHeart AttackHeart Disease10082206NL-OMON34504Anthera Pharmaceuticals, Inc576